The findings? Zepbound led to an average weightloss of 20.2 percent compared to Wegovy's 13.7 percent. We talked with healthcare experts to understand the study's findings, what sets these ...
A preliminary study on popular weight loss drugs finds participants shed more weight on Zepbound than on Novo Nordisk’s Wegovy, Zepbound maker Eli Lilly said.
Zepbound helps aid weightloss. Research consistently suggests people with overweight or obesity have more average weightloss on Zepbound than a placebo. The active ingredient in ...
Share on Pinterest Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weightloss. Shelby Knowles/Bloomberg via Getty Images Zepbound led to more ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity ...
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weightloss is most effective at helping people lose more weight in less time.